The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis
Open accessAbstract
Metabolic dysfunction-associated steatohepatitis (MASH) is associated with the activation of Kupffer cells (KCs) and hepatic stellate cells, at which point a metabolically stressed hepatocyte becomes integral to the progression of the disease. We observed a significant reduction in the level of alpha-1-antitrypsin (A1AT), a hepatocyte-derived secreted factor, in both patients with MASH and mice fed a fast-food diet (FFD). KC-mediated hepatic inflammation, most notably IL-1β, led to the transcriptional inhibition of A1AT by HNF4α. In quintuple Serpina1a–e knockout mice, ablation of A1AT worsened MASH through increased activity of proteinase 3 (PR3), a proinflammatory protease produced by F4/80 hi/CD11b low/TIM4−/CCR2+ monocyte-derived KCs (MoKCs). Conversely, A1AT restoration or PR3 inhibition mitigated MASH progression. A PR3-bound cytokine array identified IL-32 as a key factor associated with MASH. Combining IL-32 with SERPINA1, the gene encoding A1AT, synergistically predicted patients at risk of MASH through univariate logistic regression analysis. Furthermore, in vivo overexpression of IL-32γ alleviated MASH induced by FFD. However, additional knockout of A1AT increased PR3 activity, consequently abolishing the anti-MASH effects of IL-32γ. Blocking PR3-mediated IL-32γ cleavage via the V104A mutation sustained its protective actions, while the PR3-cleaved C-terminal fragment activated KCs. Additionally, after cleavage, the antifibrogenic effect of IL-32γ is lost, resulting in a failure to prevent the activation of hepatic stellate cells. This study highlights the critical role of hepatocyte-derived A1AT in the PR3/IL-32γ axis during MASH development. Strategies to correct A1AT dysregulation, such as A1AT supplementation or PR3 inhibition with sivelestat, may offer protection against the development and progression of MASH and fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ShinyGO: a graphical gene-set enrichment tool for animals and plants
Ge, S. X., Jung, D., & Yao, R. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz931 · Cited by 5,270 · cited 1×
“The enrichment analysis 27 of the upregulated proteins revealed associations with diabetes and MASLD-related pathways, including cholesterol metabolism, fat digestion and absorption, complement and coagulation cascades, and lipids and atherosclerosis (Supplementary Fig.”
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000520 · Cited by 3,476
Mapping and analysis of chromatin state dynamics in nine human cell types
Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399 · cited 2×
“The increasing prevalence, progression and serious consequences of MASLD have escalated it to become a global health priority 2,3 .”
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · cited 1×
“The increasing prevalence, progression and serious consequences of MASLD have escalated it to become a global health priority 2,3 .”
Neutrophil serine proteases: specific regulators of inflammation
Pham, C. T. N. (2006) · Nature Reviews Immunology · doi:10.1038/nri1841 · Cited by 1,022
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
Korkmaz, B., Horwitz, M. S., Jenne, D. E., & Gauthier, F. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002733 · Cited by 870 · cited 1×
“Previous studies have established that neutrophils are the primary source of PR3 secretion 11,12 .”
Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance
Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01774.x · Cited by 597
Immune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573
Cited by
Zhang, C.-Y., Liu, S., Sui, Y., & Yang, M. J. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i11.113756 · Cited by 15
Boesch, M., Anak, S., Abyad, D. E., Ostyn, T., Antoranz, A., Van, T. M., Newhouse, D., Myers, C., Melkebeke, L. V., Palmer, J. M., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02600-3 · Cited by 17
Ouyang, R., Li, X., Hao, J., Lin, J., Lan, H. Y., Peng, J., Li, X., Tian, Z., & Sun, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1708240 · Cited by 5
Hu, K., Liu, S., Sheng, S., Zhang, S., Li, B., Sun, B., & Xia, A. (2026) · iLiver · doi:10.1016/j.iliver.2026.100234 · Cited by 5
“47 As the disease progresses, hepatocyte lipotoxicity intensifies, and necrosis and cellular stress trigger the release of substantial inflammatory signals and chemokines, including C –”
Se-Ran, Y., & Kim, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178504 · Cited by 3
“Moreover, Serpina1a-e knockout mice, ablation of A1AT worsened metabolic dysfunction-associated steatohepatitis through increased activity of proteinase 3 and F4/80 hi /CD11b low /TIM4 − /CCR2 + monocyte-derived KCs [55].”
Metadata
- Authors
- Park, J.-S., Lee, J., Wang, F., Ma, H., Zhou, Z., Lee, Y.-S., Oh, K., Lee, H., Sui, G., Lee, S., Yang, Y. M., Lee, J.-W., Ji, Y.-H., Park, C.-W., Yoo, H.-S., Hwang, B.-Y., Han, S.-B., Song, N., Oh, S., Kim, B., Seki, E., Hong, J. T., & Roh, Y. S.
- Affiliations
- Chungbuk National University (KR)
- Fujian Medical University (CN)
- Ministry of Food and Drug Safety (KR)
- Korea University (KR)
- Sungkyunkwan University (KR)
- Kangwon National University (KR)
- University of California San Diego (US)
- Jeonbuk National University (KR)
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Hong, Jin Tae
- Roh, Yoon Seok
- ORCID
- Venue
- Experimental & Molecular Medicine
- Published
- 2025-02-12
- Volume
- 57
- Issue
- 2
- Pages
- 450-465
- ISSN
- 1226-3613 (ISSN-L)
- 2092-6413
- PMC
- PMC11873038
- OpenAlex
- W4407419411
- Cited by
- 15
- References
- 62
- Citations by year
- 2026: 8 · 2025: 7
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Experimental & Molecular Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- American Association for the Study of Liver Diseases
- National Research Foundation (2021RIS‐001, 2017R1A5A2015541)
- Konkuk University
- National Research Foundation of Korea (2021RIS-001, 2019R1A2C1090178, 2017R1A5A2015541)
- Fujian Medical University
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- alpha-1 antitrypsin deficiency, Pr3+, neutrophil elastase, Kupffer cells, MASH, liver fibrosis, hepatic stellate cell activation, HNF4α, IL-1β, sivelestat, liver inflammation
- MeSH terms
- alpha 1-Antitrypsin, Animals, Humans, Interleukins, Kupffer Cells, Liver Cirrhosis, Male, Mice, Inbred C57BL, Mice, Knockout, Hepatocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis. https://app.cochat.ai/papers/10.1038/s12276-025-01408-1
- The paper
- Park, J.-S., Lee, J., Wang, F., Ma, H., Zhou, Z., Lee, Y.-S., Oh, K., Lee, H., Sui, G., Lee, S., Yang, Y. M., Lee, J.-W., Ji, Y.-H., Park, C.-W., Yoo, H.-S., Hwang, B.-Y., Han, S.-B., Song, N., Oh, S., . . . Roh, Y. S. (2025). A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-025-01408-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.